Almirall

Most of the 64 million COPD patients around the world, including over 2 million in Spain, must contend with breathlessness, excessive mucus, chronic cough and other debilitating symptoms throughout  24hours a day The World Health Organization estimates that COPD kills … Read the full press release →

Barcelona,  05-8-2013 — /EuropaWire/ — Almirall’s H1: Executing on growth platforms, financial delivery on track Financial performance in line with guidance Aclidinium now available in 13 countries with five new launches planned before year’s end US/EU filings of aclidinium/formoterol combination are … Read the full press release →

The NAR and the 9th symposium on respiratory diseases reflect Almirall’s commitment to patients and its support and training for professionals Aclidinium, Almirall’s proprietary R&D medicine for the relief of Chronic Obstructive Pulmonary Disease (COPD) symptoms through its user-friendly delivery … Read the full press release →